Literature DB >> 8891135

Simultaneous pharmacodynamic analysis of the lag and bactericidal phases exhibited by beta-lactams against Escherichia coli.

R C Li1.   

Abstract

Antibiotic-bacterium interactions are complex in nature. In many cases, bacterial killing does not commence immediately after the addition of an antibiotic, and a lag period is observed. Antibiotic permeation and/or the intermediate steps that exist between antibiotic-receptor binding and expression of cell death are two major possible causes for such lag period. This study was primarily designed to determine the relationship, if any, between antibiotic concentrations and the lag periods by a modeling approach. Short-term time-kill studies were conducted for amoxicillin, ampicillin, penicillin-G, oxacillin, and dicloxacillin against Escherichia coli. In conjunction with the use of a saturable rate model to describe the concentration-dependent killing process, a first-order induction (initiation) rate constant was used to characterize the delay in bacterial killing during the lag period. For all of the beta-lactams tested, parameters describing the bactericidal effect suggest that amoxicillin and ampicillin were much more potent than oxacillin and dicloxacillin. The induction rate constant estimates for both ampicillin and amoxicillin were found to relate linearly to concentrations. Nevertheless, these induction rate constant estimates were lower for penicillin-G, oxacillin, and dicloxacillin and increased nonlinearly with concentrations until an apparent plateau was observed. These findings support the hypothesis that the permeation process is potentially a rate-limiting step for the rapid bactericidal beta-lactams such as ampicillin and amoxicillin. However, as suggested by previous observations of the various morphological changes induced by beta-lactams, the contribution of the steps following antibiotic-receptor complex formation to the lag period might be significant for the less bactericidal antibiotics such as oxacillin and dicloxacillin. Findings from the present modeling approach can potentially be used to guide future bench experimentation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891135      PMCID: PMC163525     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Microbial kinetics of drug action against gram-positive and gram-negative organisms. II: Effect of clindamycin on Staphylococcus aureus and Escherichia coli.

Authors:  S M Heman-Ackah
Journal:  J Pharm Sci       Date:  1975-10       Impact factor: 3.534

2.  Microbial kinetics of drug action against gram-positive and gram-negative organisms. I. Effect of lincomycin on Staphylococcus aureus and Escherichia coli.

Authors:  S M Heman-Ackah
Journal:  J Pharm Sci       Date:  1974-07       Impact factor: 3.534

3.  Kinetics and mechanisms of action of trimethoprim and sulfonamides, alone or in combination, upon Escherichia coli.

Authors:  J K Seydel; E Wempe; G H Miller; L Miller
Journal:  Chemotherapy       Date:  1972       Impact factor: 2.544

4.  Comparative activities of ampicillin, epicillin and amoxycillin in vitro and in vivo.

Authors:  M J Basker; M N Gwynn; A R White
Journal:  Chemotherapy       Date:  1979       Impact factor: 2.544

5.  Microbial kinetics of beta-lactam antibiotics against Escherichia coli.

Authors:  A Tsuji; S Hamano; T Asano; E Nakashima; T Yamana; S Mitsuhashi
Journal:  J Pharm Sci       Date:  1984-10       Impact factor: 3.534

6.  Pharmacodynamic modeling of bacterial kinetics: beta-lactam antibiotics against Escherichia coli.

Authors:  R C Li; D E Nix; J J Schentag
Journal:  J Pharm Sci       Date:  1994-07       Impact factor: 3.534

Review 7.  From penicillin-binding proteins to the lysis and death of bacteria: a 1979 view.

Authors:  A Tomasz
Journal:  Rev Infect Dis       Date:  1979 May-Jun

8.  Affinities of penicillins and cephalosporins for the penicillin-binding proteins of Escherichia coli K-12 and their antibacterial activity.

Authors:  N A Curtis; D Orr; G W Ross; M G Boulton
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

9.  Penicillin-binding proteins in bacteria.

Authors:  N H Georgopapadakou; F Y Liu
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

10.  Ampicillin susceptibility and ampicillin-induced killing rate of Escherichia coli.

Authors:  I P Thonus; P Fontijne; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

View more
  4 in total

Review 1.  Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

Authors:  R C Li; M Zhu; J J Schentag
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

2.  Classic reaction kinetics can explain complex patterns of antibiotic action.

Authors:  Pia Abel Zur Wiesch; Sören Abel; Spyridon Gkotzis; Paolo Ocampo; Jan Engelstädter; Trevor Hinkley; Carsten Magnus; Matthew K Waldor; Klas Udekwu; Ted Cohen
Journal:  Sci Transl Med       Date:  2015-05-13       Impact factor: 17.956

3.  Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa.

Authors:  Jürgen B Bulitta; Neang S Ly; Jenny C Yang; Alan Forrest; William J Jusko; Brian T Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

4.  Correlating Drug-Target Kinetics and In vivo Pharmacodynamics: Long Residence Time Inhibitors of the FabI Enoyl-ACP Reductase.

Authors:  Fereidoon Daryaee; Andrew Chang; Johannes Schiebel; Yang Lu; Zhuo Zhang; Kanishk Kapilashrami; Stephen G Walker; Caroline Kisker; Christoph A Sotriffer; Stewart L Fisher; Peter J Tonge
Journal:  Chem Sci       Date:  2016-05-25       Impact factor: 9.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.